Combined ipilimumab and nivolumab first-line and after BRAF-directed targeted therapies in advanced melanoma patients

H. C. Dearden, R. Mason, B. Nguyen, J. A. Soon, J. L. Smith, M. Randhawa, A. Mant, L. Warburton, S. Lo, T. Meniawy, A. Guminski, P. Parente, S. Ali, A. Haydon, G. V. Long, M. S. Carlino, M. Millward, V. G. Atkinson, A. M. Menzies

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Pages (from-to)448-448
Number of pages1
JournalAnnals of Oncology
Publication statusPublished - Oct 2018
Externally publishedYes
Event43rd ESMO Congress (ESMO) - Munich, Germany
Duration: 19 Oct 201823 Oct 2018

Cite this